LivaNova PLC $LIVN Shares Acquired by Voya Investment Management LLC

Key Points

• Voya Investment Management LLC increased its stake in LivaNova PLC by 61.2% in Q1, holding approximately 149,358 shares valued at about $5.87 million.
• Several institutional investors, such as AQR Capital Management and Hotchkis & Wiley, also raised their positions significantly during the same quarter, indicating growing interest in the company.
• LivaNova's stock has a consensus target price of $59.71 from analysts, with six ratings as "buy" and one as "hold," suggesting positive market sentiment.

Voya Investment Management LLC lifted its holdings in shares of LivaNova PLC (NASDAQ:LIVN - Free Report) by 61.2% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 149,358 shares of the company's stock after purchasing an additional 56,707 shares during the quarter. Voya Investment Management LLC owned about 0.27% of LivaNova worth $5,867,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in LIVN. AQR Capital Management LLC lifted its position in LivaNova by 111.7% during the first quarter. AQR Capital Management LLC now owns 1,571,295 shares of the company's stock worth $60,809,000 after buying an additional 829,115 shares during the period. Nuveen LLC purchased a new position in shares of LivaNova during the 1st quarter worth about $30,954,000. Hotchkis & Wiley Capital Management LLC lifted its holdings in shares of LivaNova by 100.7% during the 1st quarter. Hotchkis & Wiley Capital Management LLC now owns 1,003,000 shares of the company's stock worth $39,398,000 after acquiring an additional 503,350 shares during the period. LSV Asset Management boosted its position in shares of LivaNova by 278.3% in the first quarter. LSV Asset Management now owns 438,498 shares of the company's stock worth $17,224,000 after acquiring an additional 322,598 shares during the last quarter. Finally, Vanguard Group Inc. grew its holdings in LivaNova by 13.5% in the first quarter. Vanguard Group Inc. now owns 2,666,880 shares of the company's stock valued at $104,755,000 after purchasing an additional 316,993 shares during the period. Hedge funds and other institutional investors own 97.64% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have weighed in on the stock. Needham & Company LLC reaffirmed a "buy" rating and set a $64.00 price target on shares of LivaNova in a research note on Wednesday, September 3rd. Wall Street Zen upgraded LivaNova from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 9th. Finally, Barclays lifted their target price on LivaNova from $55.00 to $58.00 and gave the company an "equal weight" rating in a report on Thursday, August 21st. Six equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $59.71.

LivaNova Stock Up 0.2%

NASDAQ:LIVN traded up $0.13 on Monday, reaching $55.13. The stock had a trading volume of 451,186 shares, compared to its average volume of 570,193. The company has a 50-day moving average of $50.96 and a 200 day moving average of $44.69. The company has a current ratio of 1.29, a quick ratio of 1.09 and a debt-to-equity ratio of 0.31. The stock has a market cap of $3.01 billion, a P/E ratio of -14.17 and a beta of 0.96. LivaNova PLC has a 12-month low of $32.48 and a 12-month high of $58.91.

LivaNova (NASDAQ:LIVN - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The company reported $1.05 EPS for the quarter, topping the consensus estimate of $0.84 by $0.21. LivaNova had a positive return on equity of 14.57% and a negative net margin of 16.13%.The business had revenue of $352.50 million for the quarter, compared to analysts' expectations of $332.20 million. During the same quarter in the previous year, the firm posted $0.93 earnings per share. The company's revenue was up 10.6% compared to the same quarter last year. On average, research analysts predict that LivaNova PLC will post 2.85 earnings per share for the current year.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.